|
POLR2D expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.620610E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.098400E-03 |
| Normal-vs-Stage2 |
7.368500E-04 |
| Normal-vs-Stage3 |
1.205410E-04 |
| Normal-vs-Stage4 |
9.88690000000014E-05 |
| Stage1-vs-Stage2 |
2.033200E-01 |
| Stage1-vs-Stage3 |
1.318620E-01 |
| Stage1-vs-Stage4 |
1.012590E-01 |
| Stage2-vs-Stage3 |
8.809600E-01 |
| Stage2-vs-Stage4 |
8.080400E-01 |
| Stage3-vs-Stage4 |
6.559200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.779100E-04 |
| Normal-vs-AfricanAmerican |
1.586030E-01 |
| Normal-vs-Asian |
8.708400E-02 |
| Caucasian-vs-AfricanAmerican |
3.283200E-01 |
| Caucasian-vs-Asian |
1.609190E-01 |
| AfricanAmerican-vs-Asian |
9.554400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72292999999213E-05 |
| Normal-vs-Female |
8.998700E-04 |
| Male-vs-Female |
4.572300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.930470E-02 |
| Normal-vs-Age(41-60Yrs) |
2.1255999999914E-05 |
| Normal-vs-Age(61-80Yrs) |
7.66600000000617E-05 |
| Normal-vs-Age(81-100Yrs) |
6.378200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.376000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.068100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.119000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.575600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.618000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.146800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.437760E-01 |
| Classical-VS-Follicular |
9.95769999789786E-09 |
| Classical-VS-Other |
4.766200E-02 |
| Classical-VS-Normal |
1.380430E-02 |
| Tall-VS-Follicular |
5.177700E-02 |
| Tall-VS-Other |
2.694800E-01 |
| Tall-VS-Normal |
4.043800E-03 |
| Follicular-VS-Other |
9.501000E-01 |
| Follicular-VS-Normal |
7.54050000217887E-09 |
| Other-VS-Normal |
4.741500E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.38989999999229E-05 |
| Normal-vs-N1 |
1.615640E-04 |
| N0-vs-N1 |
4.242200E-01 |
|
|
